Mandatory NPO status for 8-12 hours, complete preoperative cardiac catheterization, assessment of pulmonary vascular resistance, blood type and cross-matching, comprehensive infectious disease screening, optimization of coagulation parameters, and anesthesia consultation for general endotracheal intubation.
Transfer to Cardiothoracic ICU with continuous hemodynamic monitoring, initiation of lifelong immunosuppressive therapy (calcineurin inhibitors, antimetabolites, and corticosteroids), strict infection control protocols, initiation of physical therapy, and frequent endomyocardial biopsies to monitor for rejection, followed by a transition to step-down unit prior to discharge.
Comprehensive Guide: Heterotopic Heart Transplantation (The "Piggyback" Procedure)
1. Introduction & Overview
Heterotopic heart transplantation, colloquially known as the "piggyback" heart transplant, represents one of the most ingenious yet rare surgical interventions in cardiothoracic medicine. Unlike orthotopic transplantation—where the diseased heart is excised and replaced by a donor organ in the native anatomical position—the heterotopic approach involves the implantation of a donor heart into the right hemithorax. The donor heart is connected in parallel with the recipient’s native heart, allowing both organs to beat simultaneously.
While orthotopic transplantation remains the gold standard for end-stage heart failure, the heterotopic procedure serves as a critical life-saving bridge or a permanent solution for patients whose pulmonary vascular resistance (PVR) is too high to support a donor heart alone. This guide provides an exhaustive clinical overview of this complex procedure.
2. Technical Specifications & Mechanisms
The Mechanical Principle
The heterotopic transplant functions as a "biological assist device." In this configuration, the donor heart is connected to the recipient's native heart via the left atrium, right atrium, pulmonary artery, and aorta.
- The Donor Heart's Role: It acts as a booster pump. Blood enters the donor heart from the recipient’s pulmonary veins and is pumped into the systemic circulation.
- The Native Heart's Role: It continues to handle a portion of the venous return and provides structural stability to the thoracic cavity.
Surgical Configuration
The donor heart is placed in the right pleural space. The surgical anastomoses include:
1. Left Atrial-to-Left Atrial anastomosis: Connecting the donor left atrium to the recipient's left atrium.
2. Right Atrial-to-Right Atrial anastomosis: Connecting the donor right atrium to the recipient's right atrium.
3. Aortic-to-Aortic anastomosis: Utilizing a vascular graft or direct side-to-side connection to ensure systemic output.
4. Pulmonary Artery-to-Pulmonary Artery anastomosis: Ensuring the donor heart receives pulmonary blood flow.
3. Clinical Indications & Usage
The primary indication for heterotopic transplantation is Fixed Pulmonary Hypertension (PH). In a standard transplant, a donor heart—accustomed to low-pressure pulmonary circulation—would fail immediately if forced to pump against the high-pressure system of a patient with severe PH (often defined by a PVR > 5-6 Wood units).
Indications Table
| Clinical Condition | Rationale for Heterotopic Approach |
|---|---|
| Severe Pulmonary Hypertension | Prevents right ventricular (RV) failure in the donor heart. |
| Size Mismatch | Allows for the use of smaller donor hearts in larger recipients. |
| Bridge to Recovery | Allows the native heart time to recover if there is potential for myocardial improvement. |
| High-Risk Recipients | Patients who cannot tolerate cardiopulmonary bypass for a full orthotopic excision. |
4. Pre-Operative Preparation
Preparation for a heterotopic transplant is more rigorous than standard procedures due to the complex hemodynamics involved.
- Right Heart Catheterization (RHC): Essential to quantify PVR and assess the reversibility of pulmonary vascular disease.
- Multidisciplinary Review: Cardiologists, surgeons, and intensivists must verify that the patient’s native heart can support the donor heart’s workload.
- Cross-Matching: Strict HLA and ABO compatibility checks to minimize the risk of hyperacute rejection.
- Immunological Priming: Initiation of induction immunosuppression (e.g., Basiliximab or Anti-thymocyte globulin) prior to surgery.
5. The Procedure: Step-by-Step
Phase I: Thoracotomy and Exposure
A median sternotomy is performed, but the dissection focuses on the right pleural space. The native heart is left in situ, and the pericardium is opened to expose the great vessels.
Phase II: The Anastomoses
- Atrial Connection: The donor heart is positioned. The left atria are connected, followed by the right atria.
- Vascular Grafting: The donor aorta is connected to the recipient's ascending aorta. Often, a Dacron graft is used to bridge the distance between the two hearts.
- Pulmonary Artery Integration: The donor PA is connected to the recipient PA to ensure proper pulmonary perfusion.
Phase III: De-airing and Reperfusion
Extreme care is taken to remove all air from both hearts. The aortic cross-clamp is removed, and both hearts are allowed to fibrillate and eventually stabilize into a sinus rhythm. The donor heart often requires internal defibrillation.
6. Post-Operative Recovery Protocol
Recovery from a piggyback transplant is intensive, typically requiring 7–14 days in the Cardiovascular Intensive Care Unit (CVICU).
- Hemodynamic Monitoring: Continuous monitoring of both hearts via echocardiography. Surgeons must distinguish between the electrical activity of the native heart (which may be arrhythmic) and the donor heart.
- Anticoagulation: Because of the complex vascular anastomoses and the risk of stasis in the native heart, long-term anticoagulation (Warfarin or DOACs) is often required.
- Immunosuppression: Triple-therapy regimen (Tacrolimus, Mycophenolate Mofetil, and Prednisone) is the standard.
- Rejection Surveillance: Endomyocardial biopsies are performed on the donor heart, as it is the primary driver of systemic circulation.
7. Risks, Side Effects, and Contraindications
Major Risks
- Thromboembolism: The native heart, if poorly contractile, can develop intracardiac thrombi, risking stroke or systemic embolism.
- Arrhythmias: The presence of two hearts increases the probability of atrial fibrillation or ventricular tachycardia.
- Infection: Prolonged surgical time increases the risk of mediastinitis.
- Chronic Rejection: Allograft vasculopathy remains a long-term threat.
Contraindications
- Active systemic infection.
- Malignancy with poor prognosis.
- Fixed, irreversible multi-organ failure (e.g., end-stage renal failure).
- Psychosocial instability preventing adherence to immunosuppression.
8. Alternative Treatments
While heterotopic transplantation is a unique solution, it is being phased out in favor of newer technologies:
- Left Ventricular Assist Devices (LVADs): Often used as a destination therapy, reducing the need for donor hearts.
- Total Artificial Heart (TAH): Used in patients with biventricular failure who are not candidates for transplantation.
- Pulmonary Vasodilator Therapy: Advanced medical management (e.g., Epoprostenol) to lower PVR, potentially making a patient eligible for a standard orthotopic transplant.
9. Frequently Asked Questions (FAQ)
1. Does the patient have two heartbeats?
Yes. On physical examination, clinicians may hear two distinct heart sounds, and an EKG will show the electrical activity of both hearts simultaneously.
2. Is the native heart removed later?
Usually, no. The native heart remains in place. However, if the native heart develops malignant arrhythmias or thrombi, a secondary procedure to excise it may be required.
3. How long do these transplants last?
Survival rates are comparable to orthotopic transplants, though morbidity is higher due to the complexity of maintaining two hearts.
4. Why not just replace the heart?
If the patient has severe pulmonary hypertension, a normal donor heart would fail from the high pressure. The heterotopic method allows the donor heart to work in a lower-pressure environment.
5. What happens if the native heart fails?
The donor heart typically provides the majority of systemic cardiac output. If the native heart fails completely, it acts as a passive space-occupier, but the donor heart remains the life-sustaining organ.
6. Is the recovery more painful?
Yes, the incision involves both the mediastinum and the right hemithorax, leading to more significant post-operative pain and a higher risk of pleural effusions.
7. Can the patient exercise?
Yes, but exercise tolerance is often limited by the underlying condition of the native heart and the potential for arrhythmias.
8. Are there special dietary restrictions?
Beyond standard post-transplant guidelines (low sodium, heart-healthy diet), patients must be careful with Vitamin K intake if they are on Warfarin for anticoagulation.
9. How is rejection diagnosed?
Biopsies are performed on the donor heart. The native heart is not typically biopsied as it is not the primary target of the donor-specific antibodies.
10. Why is this procedure becoming rarer?
The development of advanced LVADs and improved pharmacological management for pulmonary hypertension has reduced the clinical necessity for heterotopic transplantation.
10. Conclusion
Heterotopic (piggyback) heart transplantation stands as a testament to the ingenuity of surgical science. While it is reserved for the most complex clinical scenarios, it provides a viable pathway to survival for patients who would otherwise be deemed "untransplantable." As medical technology evolves, the role of this procedure may shift, but its place in the history of thoracic surgery remains solidified as a landmark intervention for end-stage heart failure complicated by pulmonary vascular disease.
Medical Disclaimer: This guide is for educational and informational purposes only. It does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or surgical procedure.